Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence challenges may be ...

The APS has combined its March Meeting and April Meeting into the Global Physics Summit, the largest physics conference in the world ...

I ’ve used my phone to stream tunes for most of my 36 years. But when I found myself scrolling TikTok for nearly three hours ...

In a new comprehensive report, our colleagues at CEAg World dive deep into the critical topics shaping the vertical farming ...

Dr. Jeanelle Morgan, professor and associate department head of biology; students Dulce Ruiz and July Morning; and Dr. Swapna Bhat, associate professor of biology, stand with the poster Ruiz and ...

Magenta Telekom is undergoing a design update, whereby from now on, the iconic "T" will be the central trademark. The brand ...

Hepatitis B virus (HBV) is the leading cause of cirrhosis, hepatocellular carcinoma, and liver-related death globally.1,2 The highest prevalence is found in low-income and middle-income countries ...

The findings of this model support KIO-104 as a promising therapeutic candidate for both the prevention and treatment of PVR.

In a report issued on March 7, Vertical Research also initiated coverage with a Buy rating on the stock with a $135.00 price target. See today’s best-performing stocks on TipRanks >> SentinelOne ...

Kate Herrmann, a junior from Mount Vernon, Illinois, presented her research on support services for neurodiverse college students at the Kentucky Capitol Building in Frankfort, Kentucky.

Analyst opinions remained positive on the shares. On March 7, analysts from Vertical Research initiated coverage on the shares with a Buy rating and a $135 price target. In early February ...

In the poster, titled, “TIM-4-L Expression on Ovarian Cancer Samples can be Targeted by Engineered Chimeric Engulfment Receptor T cells without Toxicity,” investigators demonstrated that CER ...